Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Avi Kapoor
ReShape Lifesciences Inc. (RSLS) shares soared by approximately 45% in pre-market trading due to FDA PMA supplement approval for its Lap-Band 2.0 FLEX. Other stocks also experienced significant movement in pre-market trading, with various gainers such as RiskOn International, Inc. (ROI) and C4 Therapeutics, Inc. (CCCC), and losers including Jin Medical International Ltd. (ZJYL) and Altisource Asset Management Corporation (AAMC).
December 13, 2023 | 12:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ReShape Lifesciences shares surged due to FDA approval for its next-generation Lap-Band 2.0 FLEX, indicating strong investor confidence in the company's regulatory progress.
FDA approvals are significant catalysts for biotech companies, often leading to increased investor confidence and stock price surges. The approval of Lap-Band 2.0 FLEX is likely to have a positive short-term impact on RSLS's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100